J7518
J7518 – Mycophenolic acid, oral, 180 mg · NDC Crosswalk & Billing Units
HCPCS Level II J-code · Medicare Part B drug billing
J-code
● 39 NDCs crosswalked per 180 MG $0.325/unit ASP+6%
📋 J7518 summary
J7518 is a HCPCS Level II J-code used to bill Mycophenolic acid, oral, 180 mg, billed per 180 MG. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.
Brand names associated with J7518: Mycophenolic Acid*, Myfortic, Mycophenolic Acid
Code J7518
Billing unit 180 MG Payment limit $0.325/unit NDC-Crosswalk 39
Quarter Q3 2026
RxCUI Atlas Trace the drug concept →
⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.
🗂️ Key billing facts
HCPCS codeJ7518
DescriptorMycophenolic acid, oral, 180 mg
Billing unit180 MG
Payment limit / unit$0.325
Est. ASP / unit$0.307 est.
Mapped NDCs39
Data periodQ3 2026
Last updated2026-08-20
💊 About Mycophenolic Acid DRUG GUIDE
Mycophenolic acid delayed-release tablets — available as the brand Myfortic and as generic mycophenolic acid delayed-release tablets — are used to prevent organ rejection in adults who have received a kidney transplant.
They are always used together with cyclosporine and corticosteroids, not alone.Myfortic and mycophenolic acid delayed-release tablets are also approved for pediatric kidney transplant patients aged 5 years and older, but only in those who are at least 6 months past their transplant.
These tablets are not interchangeable with mycophenolate mofetil (MMF) tablets or capsules without a doctor's supervision.
Clinical overview from our editorial drug guide for Mycophenolic Acid. For billing reference, see the sections above.
🧾 Billing & reimbursement HCPCS · CMS · EFF. Q3 2026
📅 Payment limits effective Q3 2026 — from the CMS Medicare Part B Payment Limit File (revised quarterly).
Medicare payment limit / unit
$0.325
Est. ASP / unit
$0.307 est.
Est. after 2% sequester
$0.319
HCPCS dosage
180 MG
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly), Q3 2026.
Full HCPCS code details (official CMS record)
Long descriptionMycophenolic acid, oral, 180 mg
CoverageD — Special coverage instructions apply
Pricing indicator51 — Drug — priced under the ASP methodology
Type of service1 — Medical care
BETOS-2O1E
ASC payment group—
Action codeN — No maintenance this year
Effective date2005-01-01
Date added2005-01-01
Source: CMS HCPCS Level II code file (imported via admin).
🧮 Dosing & billing-units calculator HCPCS UNITS
One billing unit of J7518 = 180 mg. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.
🔁 NDCs that bill under J7518 LEAST EXPENSIVE FIRST
39 NDCs map to J7518. Bill units = how many HCPCS units one package represents. Est. pay / pkg = payment limit ($0.325/unit) × that package's bill units.
| NDC (11-digit) | Drug | Labeler | Package | Strength | Bill units | Est. pay / pkg | NADAC / unit | Status | Source |
|---|---|---|---|---|---|---|---|---|---|
| 00904-6785-04 | Mycophenolic Acid 180 mg/1 TABLET, DELAYED RELEASE | Major | 30 BLISTER PACK in 1 CARTON (0904-6785-04)... | 180 mg/1 | 30 | $9.75 | $0.099 | ● Active | CMS + PDAC |
| 00904-6785-61 | Mycophenolic Acid 180 mg/1 TABLET, DELAYED RELEASE | Major | 100 BLISTER PACK in 1 CARTON (0904-6785-61... | 180 mg/1 | 100 | $32.50 | $0.099 | ● Active | CMS + PDAC |
| 16729-0261-29 | Mycophenolic Acid 180 mg/1 TABLET, DELAYED RELEASE | Accord | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (1... | 180 mg/1 | 120 | $39.00 | $0.099 | ● Active | CMS + PDAC |
| 24979-0160-44 | mycophenolic acid 180 mg/1 TABLET, DELAYED RELEASE | Upsher-Smith | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (2... | 180 mg/1 | 120 | $39.00 | $0.099 | ● Active | CMS + PDAC |
| 59651-0621-08 | MYCOPHENOLIC ACID 180 mg/1 TABLET, DELAYED RELEASE | Aurobindo | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (5... | 180 mg/1 | 120 | $39.00 | $0.099 | ● Active | CMS + PDAC |
| 60505-2965-07 | Mycophenolic Acid 180 mg/1 TABLET, DELAYED RELEASE | Apotex | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (6... | 180 mg/1 | 120 | $39.00 | $0.099 | ● Active | CMS + PDAC |
| 67877-0426-12 | MYCOPHENOLIC ACID 180 mg/1 TABLET, DELAYED RELEASE | Ascend | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (6... | 180 mg/1 | 120 | $39.00 | $0.099 | ● Active | CMS + PDAC |
| 68084-0907-21 | Mycophenolic Acid 180 mg/1 TABLET, DELAYED RELEASE | American | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084... | 180 mg/1 | 30 | $9.75 | $0.099 | ● Active | CMS ASP |
| 70377-0039-11 | Mycophenolic Acid 180 mg/1 TABLET, DELAYED RELEASE | Biocon | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (7... | 180 mg/1 | 120 | $39.00 | $0.099 | ● Active | CMS + PDAC |
| 70377-0126-11 | Mycophenolic Acid 180 mg/1 TABLET, DELAYED RELEASE | Biocon | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (7... | 180 mg/1 | 120 | $39.00 | $0.099 | ● Active | CMS + PDAC |
| 72819-0155-08 | Mycophenolic Acid mycophenilic 180 mg/1 TABLET, DELAYED RELEASE | Archis | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (7... | 180 mg/1 | 120 | $39.00 | $0.099 | ● Active | CMS + PDAC |
| 72888-0199-12 | mycophenolic acid 180 mg/1 TABLET, DELAYED RELEASE | Advagen | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (7... | 180 mg/1 | 1 | $0.33 | $0.099 | ● Active | PDAC |
| 70436-0172-23 | Mycophenolic Acid 180 mg/1 TABLET, DELAYED RELEASE | Slate | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (7... | 180 mg/1 | 120 | $39.00 | $0.117 | ● Active | CMS + PDAC |
| 00904-6786-04 | Mycophenolic Acid 360 mg/1 TABLET, DELAYED RELEASE | Major | 30 BLISTER PACK in 1 CARTON (0904-6786-04)... | 360 mg/1 | 60 | $19.50 | $0.226 | ● Active | CMS + PDAC |
| 00904-6786-61 | Mycophenolic Acid 360 mg/1 TABLET, DELAYED RELEASE | Major | 100 BLISTER PACK in 1 CARTON (0904-6786-61... | 360 mg/1 | 200 | $65.00 | $0.226 | ● Active | CMS + PDAC |
| 24979-0161-44 | mycophenolic acid 360 mg/1 TABLET, DELAYED RELEASE | Upsher-Smith | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (2... | 360 mg/1 | 240 | $78.00 | $0.226 | ● Active | CMS + PDAC |
| 59651-0622-08 | MYCOPHENOLIC ACID 360 mg/1 TABLET, DELAYED RELEASE | Aurobindo | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (5... | 360 mg/1 | 240 | $78.00 | $0.226 | ● Active | CMS + PDAC |
| 60505-2966-07 | Mycophenolic Acid 360 mg/1 TABLET, DELAYED RELEASE | Apotex | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (6... | 360 mg/1 | 240 | $78.00 | $0.226 | ● Active | CMS + PDAC |
| 67877-0427-12 | MYCOPHENOLIC ACID 360 mg/1 TABLET, DELAYED RELEASE | Ascend | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (6... | 360 mg/1 | 240 | $78.00 | $0.226 | ● Active | CMS + PDAC |
| 68084-0918-25 | Mycophenolic Acid 360 mg/1 TABLET, DELAYED RELEASE | American | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084... | 360 mg/1 | 60 | $19.50 | $0.226 | ● Active | CMS ASP |
| 70377-0040-11 | Mycophenolic Acid 360 mg/1 TABLET, DELAYED RELEASE | Biocon | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (7... | 360 mg/1 | 240 | $78.00 | $0.226 | ● Active | CMS + PDAC |
| 70377-0127-11 | Mycophenolic Acid 360 mg/1 TABLET, DELAYED RELEASE | Biocon | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (7... | 360 mg/1 | 240 | $78.00 | $0.226 | ● Active | CMS + PDAC |
| 72819-0156-08 | Mycophenolic Acid mycophenilic 360 mg/1 TABLET, DELAYED RELEASE | Archis | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (7... | 360 mg/1 | 240 | $78.00 | $0.226 | ● Active | CMS + PDAC |
| 72888-0200-12 | mycophenolic acid 360 mg/1 TABLET, DELAYED RELEASE | Advagen | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (7... | 360 mg/1 | 2 | $0.65 | $0.226 | ● Active | PDAC |
| 16729-0189-29 | Mycophenolic Acid 360 mg/1 TABLET, DELAYED RELEASE | Accord | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (1... | 360 mg/1 | 2 | $0.65 | $0.226 | ● Active | PDAC |
| 70436-0173-23 | Mycophenolic Acid 360 mg/1 TABLET, DELAYED RELEASE | Slate | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (7... | 360 mg/1 | 240 | $78.00 | $0.237 | ● Active | CMS + PDAC |
| 00078-0385-66 | Myfortic mycophenolic acid 180 mg/1 TABLET, DELAYED RELEASE | Novartis | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (0... | 180 mg/1 | 120 | $39.00 | $7.433 | ● Active | CMS + PDAC |
| 00078-0386-66 | Myfortic mycophenolic acid 360 mg/1 TABLET, DELAYED RELEASE | Novartis | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (0... | 360 mg/1 | 240 | $78.00 | $14.934 | ● Active | CMS + PDAC |
| 50090-6492-00 | MYCOPHENOLIC ACID 360 mg/1 TABLET, DELAYED RELEASE | A-S | 180 TABLET, DELAYED RELEASE in 1 BOTTLE (5... | 360 mg/1 | 360 | $117.00 | — | ● Active | CMS ASP |
| 50268-0559-12 | Mycophenolic Acid DR | AvPAK | — | — | 20 | $6.50 | — | — | CMS + PDAC |
| 00904-7372-61 | MYCOPHENOLIC ACID 360 mg/1 TABLET, DELAYED RELEASE | Major | 100 BLISTER PACK in 1 CARTON (0904-7372-61... | 360 mg/1 | 2 | $0.65 | — | ● Active | PDAC |
| 50268-0560-12 | MYCOPHENOLIC ACID AVPAK (ENTERIC COATED) 360 MG | Unknown | — | — | 2 | $0.65 | — | — | PDAC |
| 70748-0217-16 | MYCOPHENOLIC ACID (FILM-COATED) 180 MG | Unknown | — | — | 1 | $0.33 | — | — | PDAC |
| 70748-0218-16 | MYCOPHENOLIC ACID (FILM-COATED) 360 MG | Unknown | — | — | 2 | $0.65 | — | — | PDAC |
| 00093-7032-89 | MYCOPHENOLIC ACID (FILM-COATED) 360 MG | Unknown | — | — | 2 | $0.65 | — | — | PDAC |
| 00093-7031-89 | MYCOPHENOLIC ACID (FILM-COATED) 180 MG | Unknown | — | — | 1 | $0.33 | — | — | PDAC |
| 51079-0508-20 | MYCOPHENOLIC ACID (FILM-COATED) 180 MG | Unknown | — | — | 1 | $0.33 | — | — | PDAC |
| 00378-4201-78 | MYCOPHENOLIC ACID (FILM-COATED) 180 MG | Unknown | — | — | 1 | $0.33 | — | — | PDAC |
| 00378-4202-78 | MYCOPHENOLIC ACID (FILM-COATED) 360 MG | Unknown | — | — | 2 | $0.65 | — | — | PDAC |
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.
📊 Medicare utilization & spend CMS · PART B · 2026 (Q1)
Period
Total Part B spend
$2.87M
Claims
57,045
Beneficiaries
24,766
Spend / beneficiary
$115.98
Spend / claim
$50.35
Trend by period
Where J7518 ranks among Part B drugs · 2026 (Q1) · neighbors ±5
Total spending — #297 of 824
#292
DOXIL* Q2050
$3M
#293
GRAFIX STRAVIX PRIME... Q4133
$2.95M
#294
KENALOG-10* J3301
$2.92M
#295
AVSOLA Q5121
$2.89M
#296
YEZTUGO(J0738) J0738
$2.88M
#297
MYCOPHENOLIC ACID* J7518
$2.87M
#298
XCELL AMNIO MATRIX P... Q4280
$2.85M
#299
ZIIHERA J9276
$2.83M
#300
QALSODY J1304
$2.72M
#301
HEMOFIL M* J7190
$2.66M
#302
ZOLADEX J9202
$2.65M
Total claims — #44 of 824
#39
PREDNISONE INTENSOL* J7512
65,179
#40
METHYLPREDNISOLONE S... J2919
61,362
#41
AFLURIA (3YR UP)* 90656
60,542
#42
EUFLEXXA J7323
60,496
#43
SODIUM CHLORIDE(J703... J7030
59,637
#44
MYCOPHENOLIC ACID* J7518
57,045
#45
IODIXANOL(Q9966)* Q9966
56,735
#46
HEPLISAV-B 90739
54,586
#47
CIMZIA (2 PACK)* J0717
53,117
#48
LEQEMBI J0174
52,011
#49
EXPAREL J0666
51,998
Top Medicare Part B drugs by the selected metric. Click any drug to open its J-code page. Source: CMS Medicare Quarterly Part B Spending by Drug.
Full breakdown by period (2)
| Period | Total spend | Beneficiaries | Claims | $/beneficiary | $/claim |
|---|---|---|---|---|---|
| 2026 (Q1) | $2.87M | 24,766 | 57,045 | $115.98 | $50.35 |
| 2025 (Q1-Q4) | $15.25M | 31,634 | 265,400 | $482.21 | $57.48 |
Provider-administered (Part B) spend, calculated for the whole HCPCS code (CMS does not publish Medicare spend per individual NDC). Self-administered use is covered under Part D instead. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part B Spending by Drug (data.cms.gov), updated quarterly.
📈 Medicare Part B claims detail CMS PSPS · 2024
Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.
Allowed charges
$15.69M
Medicare paid
$11.52M
Submitted services
42,296,562
Denial rate
4.0%
Allowed / service
$0.39
Submitted charges
$168.2M
Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.
📊 What bills under J7518
J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.
NDC products by ingredient
NDC products by labeler
🗃️ Data sources & freshness
Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Loaded
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Q3 2026 · as of 2026-08-20
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)
39 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
Latest data year 2026
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.
⚠️ Practical billing caveats
- A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
- Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
- Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
- Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
- The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
- Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.
❓ J7518 billing FAQ
What is HCPCS code J7518?
J7518 is a HCPCS Level II J-code used to bill Mycophenolic acid, oral, 180 mg under Medicare Part B and most medical (not pharmacy) benefits.
What is the billing unit for J7518?
One unit of J7518 represents 180 MG. Report the number of units equal to the dose administered divided by 180 MG.
How many units of J7518 should I bill?
Divide the dose administered by the code's unit size (180 MG) to get the number of billing units, then round per your payer's policy. The calculator on this page converts a dose into billing units and projects a full course.
How much does Medicare pay for J7518?
The Medicare Part B payment limit is $0.325 per unit (Q3 2026), based on ASP + 6%. After the 2% sequester the effective payment is about $0.319 per unit. Payment limits are revised quarterly.
Which NDCs bill under J7518?
39 NDCs currently map to J7518 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J7518 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.